Skip to content

    Sree Rayalaseema Hi-Strength Hypo Limited

    Chemicals
    Commodities

    Overview

    Price

    Market Cap

    ₹820 Cr

    Sector

    Chemicals

    Commodities

    Rank

    Performance

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly

    Balance Sheet

    Balance Sheet

    ₹ Cr · Annual
    Line itemFY20FY21FY22FY23FY24FY25FY26FY26
    LiabilitiesEquity Capital1717171717171717
    Reserves294371553734785905993959
    Borrowings577228165151311
    Other Liabilities7659189174100121133119
    Total Liabilities4455197879419071.1k1.2k1.1k
    AssetsFixed Assets161134130105103112111111
    CWIP30000000
    Investments1850164268253366407324
    Other Assets262334494568551580638672
    Total Assets4455197879419071.1k1.2k1.1k

    Cash Flow

    Cash Flow

    ₹ Cr · Annual
    Line itemFY19FY20FY21FY22FY23FY24FY25FY26
    ActivitiesCash from Operating609971601311328839
    Cash from Investing-24-38-115-1-99-8-4038
    Cash from Financing-37-2210-52-20-22-8-11
    SummaryCapital Expenditure
    Free Cash Flow159150461361238537
    FCF Margin

    Valuation

    Assumptions

    Current — SRHHYPOLTD
    Price
    ₹491
    EPS (TTM)
    ₹53.98
    PE (TTM)
    9.1
    Profit growth
    -13.4%

    The Earnings Per Share over the last 12 months.

    %

    Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).

    Pre-filled with the lower of median (9.5×) and current (9.1×) PE — the conservative anchor.

    %

    The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.

    Valuation

    Current price
    ₹491
    vs
    Fair value · 15% return
    ₹91
    82%Overvalued

    At -13.4% growth and a 9× exit, ₹491 only delivers your return if you pay ₹91. The price is currently baking in 18% growth.

    EPS grows -13.4%/yr for 5 years, then fades to 6% over 2, exits at 9×.

    YearGrowthEPS (₹)
    FY27-13.4%46.75
    FY28-13.4%40.48
    FY29-13.4%35.06
    FY30-13.4%30.36
    FY31-13.4%26.29
    FY32-3.7% ·fade25.32
    FY336.0% ·fade26.84

    Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.

    Learn to analyse Sree Rayalaseema Hi-Strength Hypo Limited

    Guides on how to read this kind of business and the numbers that matter.